Inventor
AHMAD SALEEM
US60 patents
⚠️ This page may combine multiple inventors who share the name “AHMAD SALEEM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
45 patentsUS6916813B2Jul 12, 2005
(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
BRISTOL MYERS SQUIBB CO80 citations96
US6887870B1May 3, 2005
Heterocyclic sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO51 citations95
US8791091B2Jul 29, 2014
Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO18 citations92
US7745447B2Jun 29, 2010
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO28 citations92
US7326705B2Feb 5, 2008
Heterocyclic sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO24 citations92
US6664250B2Dec 16, 2003
Lactam derivatives as antiarrhythmic agents
BRISTOL MYERS SQUIBB CO30 citations92
US6624309B1Sep 23, 2003
Benzoic acid derivatives and related compounds as antiarrhythmic agents
BRISTOL MYERS SQUIBB CO33 citations92
US6262068B1Jul 17, 2001
Lactam derivatives as antiarrhythmic agents
BRISTOL MYERS SQUIBB CO49 citations92
US5314893AMay 24, 1994
Antiviral tetrahydropyrans
BRISTOL MYERS SQUIBB CO29 citations92
US9896431B2Feb 20, 2018
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO5 citations84
US9688629B2Jun 27, 2017
Indole carboxamide compounds
BRISTOL MYERS SQUIBB CO6 citations84
US9688656B2Jun 27, 2017
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US7973159B2Jul 5, 2011
Non-basic melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO10 citations84
US7851622B2Dec 14, 2010
Non-basic melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO10 citations84
US7371759B2May 13, 2008
HMG-CoA reductase inhibitors and method
BRISTOL MYERS SQUIBB CO11 citations84
US6048877AApr 11, 2000
Tetralone derivatives as antiarrhythmic agents
BRISTOL MYERS SQUIBB CO16 citations84
US9901572B2Feb 27, 2018
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO6 citations83
US9663466B2May 30, 2017
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO8 citations83
US9187424B1Nov 17, 2015
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US8012984B2Sep 6, 2011
Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods
BRISTOL MYERS SQUIBB CO7 citations83
US7618980B2Nov 17, 2009
Pyrrolo(oxo)quinolines as 5HT ligands
BRISTOL MYERS SQUIBB CO11 citations83
US7572805B2Aug 11, 2009
Pyrrolo(oxo)isoquinolines as 5HT ligands
BRISTOL MYERS SQUIBB CO12 citations83
US9365558B2Jun 14, 2016
Dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO9 citations82
US6011059AJan 4, 2000
Acyl guanidine sodium/proton exchange inhibitors and method
BRISTOL MYERS SQUIBB CO14 citations74
US5414096AMay 9, 1995
Antiviral tetrahydropyrans
BRISTOL MYERS SQUIBB CO7 citations74
US10538505B2Jan 21, 2020
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US10329273B2Jun 25, 2019
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US10093650B2Oct 9, 2018
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US10695328B2Jun 30, 2020
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10369140B2Aug 6, 2019
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US6160134ADec 12, 2000
Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
BRISTOL MYERS SQUIBB CO8 citations71
US11479538B2Oct 25, 2022
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO0 citations63
US9920031B2Mar 20, 2018
Indole carboxamide compounds
BRISTOL MYERS SQUIBB CO1 citations63
US5414000AMay 9, 1995
Antiviral pyrinyl substituted tetrahydropyrans
BRISTOL MYERS SQUIBB CO4 citations63
US11623921B2Apr 11, 2023
Indole carboxamide compounds
BRISTOL MYERS SQUIBB CO0 citations62
US11053197B2Jul 6, 2021
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations62
US10966967B2Apr 6, 2021
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US9802915B2Oct 31, 2017
Indole carboxamide compounds
BRISTOL MYERS SQUIBB CO1 citations62
US7238702B2Jul 3, 2007
Dihydroquinazolinones as 5HT modulators
BRISTOL MYERS SQUIBB CO3 citations62
US9499482B2Nov 22, 2016
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO2 citations57
US12304916B2May 20, 2025
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US10604504B2Mar 31, 2020
Indole carboxamide compounds
BRISTOL MYERS SQUIBB CO0 citations52
US10329274B2Jun 25, 2019
Indole carboxamide compounds
BRISTOL MYERS SQUIBB CO0 citations52
US10023534B2Jul 17, 2018
Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK
BRISTOL MYERS SQUIBB CO1 citations52
US12492186B2Dec 9, 2025
Bicyclic heterocyclic compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
SQUIBB & SONS INC
2 patentsUS5344962ASep 6, 1994
Intermediates in the synthesis of an optically active cyclobutane nucleoside
SQUIBB & SONS INC2 citations63
US5233076AAug 3, 1993
Process for preparing an optically active cyclobutanone, an intermediate in the synthesis of an optically active cyclobutane nucleoside
SQUIBB & SONS INC4 citations63
UNIV NEW YORK STATE RES FOUND
1 patentSTEIN PHILIP D
1 patentDEVASTHALE PRATIK
1 patentShowing the top 50 of 60 patents by PatentIndex Score.